Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Media
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsShortsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Jan Van Meerbeeck, MD

Advertisement

Articles by Jan Van Meerbeeck, MD

Cisplatin/Paclitaxel vs Cisplatin/Teniposide for Advanced Non-Small-Cell Lung Cancer

ByGiuseppe Giaccone, MD, PhD,Pieter E. Postmus, MD, PhD,Ted A. W. Splinter, MD,Maria Diaz-puente, MD,Nico Van Zandwijk, MD, PhD,Giorgio V. Scagliotti, MD, PhD,Andrea Ardizzoni, MD,Jan Van Meerbeeck, MD,Channa Debruyne, MD,Tarek Sahmoud, MD
April 1st 1997

A total of 332 patients with advanced non-small-cell lung cancer were randomized by the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative

Advertisement

Latest Updated Articles

  • Cisplatin/Paclitaxel vs Cisplatin/Teniposide for Advanced  Non-Small-Cell Lung Cancer
    Cisplatin/​Paclitaxel vs Cisplatin/​Teniposide for Advanced Non-Small-Cell Lung Cancer

    April 1st 1997



Advertisement
Advertisement

Trending on CancerNetwork

1

CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma

2

Key Takeaways for Multidisciplinary Lung Cancer Care From WCLC 2026

3

Neoantigen Vaccine Shows Encouraging Activity in Head and Neck Cancer

4

NCCN Guidelines Strengthen MRD Testing Recommendations in Multiple Myeloma

5

What Were the Key Hematologic Oncology Takeaways from SOHO 2026?

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us